Accuray (ARAY) Reports Break-Even Earnings for Q4

Company Performance - Accuray (ARAY) reported break-even quarterly earnings per share, compared to the Zacks Consensus Estimate of $0.03, and earnings of $0.03 per share a year ago, resulting in an earnings surprise of -100.00% [1] - The company posted revenues of $127.54 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.49%, but down from year-ago revenues of $134.29 million [2] - Over the last four quarters, Accuray has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - Accuray shares have lost about 25.3% since the beginning of the year, while the S&P 500 has gained 9.6% [3] - The current consensus EPS estimate for the coming quarter is -$0.03 on revenues of $103.7 million, and -$0.04 on revenues of $452.65 million for the current fiscal year [7] Industry Outlook - The Zacks Medical - Instruments industry is currently in the bottom 39% of over 250 Zacks industries, indicating potential challenges for stocks within this sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Accuray's stock performance [5]